CN108157858A - A kind of compound lozenge of fructus hippophae leaf - Google Patents
A kind of compound lozenge of fructus hippophae leaf Download PDFInfo
- Publication number
- CN108157858A CN108157858A CN201711422418.1A CN201711422418A CN108157858A CN 108157858 A CN108157858 A CN 108157858A CN 201711422418 A CN201711422418 A CN 201711422418A CN 108157858 A CN108157858 A CN 108157858A
- Authority
- CN
- China
- Prior art keywords
- parts
- sea
- buckthorn
- leaf
- fructus hippophae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000229143 Hippophae Species 0.000 title claims abstract description 90
- 235000003935 Hippophae Nutrition 0.000 title claims abstract description 51
- 239000007937 lozenge Substances 0.000 title claims abstract description 34
- 150000001875 compounds Chemical class 0.000 title claims abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 43
- 239000000843 powder Substances 0.000 abstract description 31
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 15
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract description 8
- 239000002699 waste material Substances 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 5
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 5
- 229920002472 Starch Polymers 0.000 abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract description 5
- 229940116229 borneol Drugs 0.000 abstract description 5
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 5
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract description 5
- 239000008107 starch Substances 0.000 abstract description 5
- 235000019698 starch Nutrition 0.000 abstract description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract description 5
- 229960002675 xylitol Drugs 0.000 abstract description 5
- 235000010447 xylitol Nutrition 0.000 abstract description 5
- 239000000811 xylitol Substances 0.000 abstract description 5
- 206010011224 Cough Diseases 0.000 abstract description 4
- 206010036790 Productive cough Diseases 0.000 abstract description 4
- 235000019359 magnesium stearate Nutrition 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 208000024794 sputum Diseases 0.000 abstract description 4
- 210000003802 sputum Anatomy 0.000 abstract description 4
- 208000020670 canker sore Diseases 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 230000001151 other effect Effects 0.000 abstract description 3
- 206010000269 abscess Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract 1
- 238000001035 drying Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 240000000950 Hippophae rhamnoides Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013861 fat-free Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003595 mist Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a kind of compound lozenges of fructus hippophae leaf, belong to plant graft technical field of cultivation.Main technical schemes are as follows：It is prepared by the raw material of following mass fraction：50 parts 60 parts of sea-buckthorn pomace Ultramicro-powder；10 parts 20 parts of Leaves of Hippophae L Ultramicro-powder；5 parts 10 parts of Seabuckthorm Seed Oil；1 part 5 parts of Radix Glycyrrhizae；1 part 4 parts of borneol；8 parts 12 parts of water soluble starch；1 part 5 parts of xylitol；1 part 3 parts of citric acid；1 part of magnesium stearate；1 part of anticaking agent.It is of the invention preferable using the progress secondary operation utilization of sea-buckthorn processing waste, production cost is not only reduced, but also reduce the discharge of production waste material.The compound lozenge of spine fruit leaf of preparation is convenient, easy to carry, full of nutrition, has many advantages, such as to alleviate abscess of throat, canker sore, relieving cough and reducing sputum and other effects, is suitble to popular taste, meets the living needs of modern.
Description
Technical field
The present invention relates to health functional food technical fields, and in particular to a kind of compound lozenge of fructus hippophae leaf.
Background technology
Sea-buckthorn is one of anaesthetic, Tibetan medicine important component, has a variety of nutritional health functions.Sea buckthorn fruit and branches and leaves etc. contain
More than the 200 kinds of bioactive substance for being conducive to health has the effect of relieving cough and reducing sputum, stomach strengthening and digestion promoting, promoting blood circulation to remove blood stasis.Sea-buckthorn
Protein, amino acid, vitamin C and flavonoid content enrich in leaf and fructus hippophae residue, and various trace elements are complete
There is preventive and therapeutic effect in face to certain diseases of cardiovascular system, have tranquilizings the mind, cardiac stimulant, resist myocardial ischemia, allevating angina pectoris break out,
Prevent the effect of coronary atherosclerotic heart disease.Sea-buckthorn (fruit, seed) oil is to disease of cardiovascular system, digestive system disease
The treatment of disease, ophthalmology disease and cervical erosion, burn, scald, knife wound and frostbite has the effect of notable, has to tumor patient
Certain treatment and the effect of auxiliary treatment.
Application No. is the 201310690530.9, applying date on December 16th, 2013 the high sea-buckthorn sugar-free buccal tablet of patent and its
Preparation method, major ingredient are sea-buckthorn Vc xeraphiums, and prepared lozenge Vc contents are high.Main purpose is to require supplementation with Vc
Crowd provides a better choice.
Application No. is patent of the 201510007039.0, applying date on January 8th, 2015 to be related to a kind of xylo-oligosaccharide sea-buckthorn
The production method of all-fruit powder lozenge, it is therefore intended that solve people in the modern life indigestion, in enteron aisle beneficial bacterium quantity it is few,
The problem of being inconvenient to absorb the various nutriments in sea-buckthorn and royal jelly.
Sea-buckthorn is all precious from head to foot, it can be achieved that no waste mine is processed.But related patents process production just with sea buckthorn fruit
Product.It is processed waste residue and simply discharges, and is not effectively utilized, has not only caused waste, but also polluted environment.
Invention content
The step of to make up the prior art, the present invention is intended to provide a kind of compound lozenge of fructus hippophae leaf, by sea buckthorn fruit, fruit
The nutrition of slag, branch, leaf etc. fully utilizes, and realizes the no waste mine processing of sea-buckthorn, the lozenge of preparation have alleviate abscess of throat,
Canker sore, relieving cough and reducing sputum and other effects.
Technical scheme is as follows：A kind of compound lozenge of fructus hippophae leaf, by the raw material preparation of following mass fraction
Into：
The anticaking agent is this field convenient source, preferred silica of the invention.
Further, the compound lozenge of fructus hippophae leaf is prepared by the raw material of following mass fraction：
Further, the compound lozenge of fructus hippophae leaf is prepared by the raw material of following mass fraction：
Further, the compound lozenge of fructus hippophae leaf is prepared by the raw material of following mass fraction：
The preparation method of the compound lozenge of fructus hippophae leaf is as follows：
(1) fructus hippophae is cleaned squeeze the juice after take sea-buckthorn pomace, dry 20min in an oven, the sea-buckthorn pomace moisture control after drying
It makes in 5wt% or so, is sea-buckthorn pomace Ultramicro-powder with wall-breaking machine crushing, cross 20 mesh sieve, ensure the uniform of pomace granularity, be conducive to
Later stage mixes with other auxiliary materials, product foreign sense good in taste.The pomace powder made dries 20-30min again, and sea-buckthorn pomace is surpassed
The moisture of micro mist is controlled in 2wt%, to ensure the purity of sea-buckthorn pomace and cleanliness；
(2) Leaves of Hippophae L cleans drying, with wall-breaking machine crushing be granular size is 20 mesh Leaves of Hippophae L Ultramicro-powders, and baking oven dries
30min, levels control is within 2wt% in Leaves of Hippophae L Ultramicro-powder；
(3) by hippophae rhamnoides seed 50 DEG C it is dry for 24 hours after, re-dry is to constant weight, water content 2wt% after crushing.By seed
Dry powder is tightly packed with fat-free filter paper, using supercritical CO2Extraction：It is 55 DEG C, extracting pressure 350Mp in extraction temperature,
2h is extracted, obtains Seabuckthorm Seed Oil；
(4) by 50 parts of -60 parts of sea-buckthorn pomace Ultramicro-powders, 10 parts of -20 parts of Leaves of Hippophae L Ultramicro-powders, 5 parts -10 parts of Seabuckthorm Seed Oil with
1 part -5 parts of Radix Glycyrrhizae, 1 part -4 parts of borneol, 8 parts -12 parts of water soluble starch, 1 part -5 parts of xylitol, 1 part -3 parts of citric acid, stearic acid
1 part of magnesium, silica 1 part are mixed, and obtain paste mixture；
(5) paste mixture for obtaining step (4) carries out tabletting, obtains the compound lozenge of fructus hippophae leaf；
(6) the compound lozenge of fructus hippophae leaf obtained step (5) carries out irradiation sterilization, and product is obtained after packaging.
Beneficial effects of the present invention are as follows：
(1) present invention is preferable carries out secondary operation utilization using sea-buckthorn processing waste, not only reduces production cost, but also
Reduce the discharge of production waste material.
(2) the compound lozenge of spine fruit leaf that prepared by the present invention is convenient, easy to carry, full of nutrition, has and alleviates throat
The advantages that swelling and pain, canker sore, relieving cough and reducing sputum and other effects, suitable popular taste, meets the living needs of modern.
Specific embodiment
With reference to specific embodiment, the present invention will be further described, if without specified otherwise, it is raw materials used it is commercially available can
.
Embodiment 1
The compound lozenge of fructus hippophae leaf is prepared as follows：
(1) fructus hippophae is cleaned squeeze the juice after take sea-buckthorn pomace, dry 20min in an oven, the sea-buckthorn pomace moisture after drying is
4wt% is sea-buckthorn pomace Ultramicro-powder with wall-breaking machine crushing, crosses 20 mesh sieve, and the pomace powder made dries 20min again, and sea-buckthorn pomace surpasses
Moisture is 2wt% in micro mist；
(2) Leaves of Hippophae L cleans drying, with wall-breaking machine crushing be granular size is 20 mesh Leaves of Hippophae L Ultramicro-powders, and baking oven dries
30min, levels are 1.8wt% in Leaves of Hippophae L Ultramicro-powder；
(3) by hippophae rhamnoides seed 50 DEG C it is dry for 24 hours after, re-dry is to constant weight, water content 2wt% after crushing.By seed
Dry powder is tightly packed with fat-free filter paper, using supercritical CO2Extraction：It is 55 DEG C, extracting pressure 350Mp in extraction temperature,
2h is extracted, obtains Seabuckthorm Seed Oil；
(4) by 50 parts of sea-buckthorn pomace Ultramicro-powders, 10 parts of Leaves of Hippophae L Ultramicro-powders, 5 parts of Seabuckthorm Seed Oil and 1 part of Radix Glycyrrhizae, borneol 4
Part, 8 parts of water soluble starch, 1 part of xylitol, 1 part of citric acid, 1 part of magnesium stearate, silica 1 part are mixed, and obtain paste
Mixture；
(5) paste mixture for obtaining step (4) carries out tabletting, obtains the compound lozenge of fructus hippophae leaf；
(6) the compound lozenge of fructus hippophae leaf obtained step (5) carries out irradiation sterilization, and product is obtained after packaging.
Can pelletize according to the compound lozenge of fructus hippophae leaf made of the method, can tabletting, have crack once in a while, finish is preferable,
Foreign body sensation is small, and sea-buckthorn flavor is apparent.
Embodiment 2
The compound lozenge of fructus hippophae leaf is prepared as follows：
(1) fructus hippophae is cleaned squeeze the juice after take sea-buckthorn pomace, dry 20min in an oven, the sea-buckthorn pomace moisture after drying is
5wt% is sea-buckthorn pomace Ultramicro-powder with wall-breaking machine crushing, crosses 20 mesh sieve, and the pomace powder made dries 30min again, and sea-buckthorn pomace surpasses
Moisture is 1.6wt% in micro mist；
(2) Leaves of Hippophae L cleans drying, with wall-breaking machine crushing be granular size is 20 mesh Leaves of Hippophae L Ultramicro-powders, and baking oven dries
30min, levels are 1wt% in Leaves of Hippophae L Ultramicro-powder；
(3) by hippophae rhamnoides seed 50 DEG C it is dry for 24 hours after, re-dry is to constant weight, water content 2wt% after crushing.By seed
Dry powder is tightly packed with fat-free filter paper, using supercritical CO2Extraction：It is 55 DEG C, extracting pressure 350Mp in extraction temperature,
2h is extracted, obtains Seabuckthorm Seed Oil；
(4) by 60 parts of sea-buckthorn pomace Ultramicro-powders, 20 parts of Leaves of Hippophae L Ultramicro-powders, 10 parts of Seabuckthorm Seed Oil and 5 parts of Radix Glycyrrhizae, borneol 4
Part, 12 parts of water soluble starch, 5 parts of xylitol, 3 parts of citric acid, 1 part of magnesium stearate, silica 1 part are mixed, and obtain cream
Shape mixture；
(5) paste mixture for obtaining step (4) carries out tabletting, obtains the compound lozenge of fructus hippophae leaf；
(6) the compound lozenge of fructus hippophae leaf obtained step (5) carries out irradiation sterilization, and product is obtained after packaging.
Can pelletize according to the compound lozenge of fructus hippophae leaf made of the method, can tabletting, have crack once in a while, finish is preferable,
Foreign body sensation is small, and sea-buckthorn flavor is apparent.
Embodiment 3
The compound lozenge of fructus hippophae leaf is prepared as follows：
(1) fructus hippophae is cleaned squeeze the juice after take sea-buckthorn pomace, dry 20min in an oven, the sea-buckthorn pomace moisture after drying is
5wt% is sea-buckthorn pomace Ultramicro-powder with wall-breaking machine crushing, crosses 20 mesh sieve, and the pomace powder made dries 30min again, and sea-buckthorn pomace surpasses
Moisture is 1.6wt% in micro mist；
(2) Leaves of Hippophae L cleans drying, with wall-breaking machine crushing be granular size is 20 mesh Leaves of Hippophae L Ultramicro-powders, and baking oven dries
30min, levels are 1wt% in Leaves of Hippophae L Ultramicro-powder；
(3) by hippophae rhamnoides seed 50 DEG C it is dry for 24 hours after, re-dry is to constant weight, water content 2wt% after crushing.By seed
Dry powder is tightly packed with fat-free filter paper, using supercritical CO2Extraction：It is 55 DEG C, extracting pressure 350Mp in extraction temperature,
2h is extracted, obtains Seabuckthorm Seed Oil；
(4) by 54 parts of sea-buckthorn pomace Ultramicro-powders, 16 parts of Leaves of Hippophae L Ultramicro-powders, 7 parts of Seabuckthorm Seed Oil and 3 parts of Radix Glycyrrhizae, borneol 1
Part, 11 parts of water soluble starch, 3 parts of xylitol, 3 parts of citric acid, 1 part of magnesium stearate, silica 1 part are mixed, and obtain cream
Shape mixture；
(5) paste mixture for obtaining step (4) carries out tabletting, obtains the compound lozenge of fructus hippophae leaf；
(6) the compound lozenge of fructus hippophae leaf obtained step (5) carries out irradiation sterilization, and product is obtained after packaging.
Can pelletize according to the compound lozenge of fructus hippophae leaf made of the method, can tabletting, free from flaw, finish is preferable, is no different
Object sense, sea-buckthorn flavor are apparent.
Claims (5)
1. a kind of compound lozenge of fructus hippophae leaf, which is characterized in that be prepared by the raw material of following mass fraction：
2. the compound lozenge of fructus hippophae leaf as described in claim 1, which is characterized in that by the raw material preparation of following mass fraction
Into：
3. the compound lozenge of fructus hippophae leaf as described in claim 1, which is characterized in that by the raw material preparation of following mass fraction
Into：
4. the compound lozenge of fructus hippophae leaf as described in claim 1, which is characterized in that by the raw material preparation of following mass fraction
Into：
5. the compound lozenge of fructus hippophae leaf as described in claim 1, which is characterized in that the anticaking agent is silica.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711422418.1A CN108157858A (en) | 2017-12-25 | 2017-12-25 | A kind of compound lozenge of fructus hippophae leaf |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711422418.1A CN108157858A (en) | 2017-12-25 | 2017-12-25 | A kind of compound lozenge of fructus hippophae leaf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108157858A true CN108157858A (en) | 2018-06-15 |
Family
ID=62520352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711422418.1A Pending CN108157858A (en) | 2017-12-25 | 2017-12-25 | A kind of compound lozenge of fructus hippophae leaf |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108157858A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108902623A (en) * | 2018-07-20 | 2018-11-30 | 山西山阳生物药业有限公司 | A kind of Xylo-oligosaccharide compounded solid beverage of Leaves of Hippophae L- |
| CN113966816A (en) * | 2021-10-25 | 2022-01-25 | 新疆农业大学 | Preparation method of sea-buckthorn whole fruit powder capable of reducing caking rate and loss rate of bioactive substances |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207920A (en) * | 1998-08-10 | 1999-02-17 | 邹元生 | Composite sea-buckthorn oil capsule |
| CN101011150A (en) * | 2007-01-11 | 2007-08-08 | 叶仁礼 | Sugar-free seabuckthorn lozenge and its preparing process |
| CN101129790A (en) * | 2007-09-20 | 2008-02-27 | 谢江丽 | Compound hippophae rhamnoides lozenge method of producing the same |
| CN102150849A (en) * | 2011-01-07 | 2011-08-17 | 中国科学院西北高原生物研究所 | Seabuckthorn and Nitraria sibirica Pall fruit powder buccal tablet and preparation method thereof |
| CN104432088A (en) * | 2013-09-16 | 2015-03-25 | 江苏天润本草生命科技有限公司 | Composite chewable tablet containing dendrobe and preparation method of composite chewable tablet |
| CN105815621A (en) * | 2015-01-08 | 2016-08-03 | 太原市智友汇科技有限公司 | Method for producing xylo-oligosaccharide sea-buckthorn whole fruit powder lozenge |
-
2017
- 2017-12-25 CN CN201711422418.1A patent/CN108157858A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207920A (en) * | 1998-08-10 | 1999-02-17 | 邹元生 | Composite sea-buckthorn oil capsule |
| CN101011150A (en) * | 2007-01-11 | 2007-08-08 | 叶仁礼 | Sugar-free seabuckthorn lozenge and its preparing process |
| CN101129790A (en) * | 2007-09-20 | 2008-02-27 | 谢江丽 | Compound hippophae rhamnoides lozenge method of producing the same |
| CN102150849A (en) * | 2011-01-07 | 2011-08-17 | 中国科学院西北高原生物研究所 | Seabuckthorn and Nitraria sibirica Pall fruit powder buccal tablet and preparation method thereof |
| CN104432088A (en) * | 2013-09-16 | 2015-03-25 | 江苏天润本草生命科技有限公司 | Composite chewable tablet containing dendrobe and preparation method of composite chewable tablet |
| CN105815621A (en) * | 2015-01-08 | 2016-08-03 | 太原市智友汇科技有限公司 | Method for producing xylo-oligosaccharide sea-buckthorn whole fruit powder lozenge |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108902623A (en) * | 2018-07-20 | 2018-11-30 | 山西山阳生物药业有限公司 | A kind of Xylo-oligosaccharide compounded solid beverage of Leaves of Hippophae L- |
| CN113966816A (en) * | 2021-10-25 | 2022-01-25 | 新疆农业大学 | Preparation method of sea-buckthorn whole fruit powder capable of reducing caking rate and loss rate of bioactive substances |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101723206B1 (en) | Pills for health supplement food comprising extracts of protaetia brebitarsis larba and manufacturing method for the same | |
| CN103704372B (en) | A kind of nourishing the stomach kidney-tonifying heath rapeseed oil | |
| CN105494844A (en) | Production method of Chinese wolfberry fruit tablet candy | |
| CN107094974A (en) | A kind of lycium ruthenicum health-care sweets and preparation method thereof | |
| CN103238798A (en) | Dendrobium nutrient tablet and preparation method | |
| CN112841648A (en) | Preparation method and application of rhizoma polygonati | |
| CN101816425B (en) | Powder mixture of whole American ginseng/giant salamander and preparation method thereof | |
| KR101627837B1 (en) | Health supplement food comprising horse bone extracts as main ingredients and sea horse and manufacturing method for the same | |
| CN108077913A (en) | A kind of preparation method of the compound lozenge of fructus hippophae leaf | |
| CN105494691A (en) | Life-nourishing soybean oil and preparation technology thereof | |
| CN103652692B (en) | Radish leaf nutritional chewable tablet and preparation method | |
| CN108157858A (en) | A kind of compound lozenge of fructus hippophae leaf | |
| CN103372047A (en) | Eucommia bark buccal tablets and preparation method thereof | |
| CN105616476A (en) | Honeysuckle flower buccal tablet and preparation method thereof | |
| CN105360558A (en) | Candies capable of expelling toxins, reducing weight and reducing blood fat and production technology of candies | |
| CN109007814A (en) | Suitable for diabetes, Anomalous lipid metablism, obesity, constipation and alimentation composition of gout crowd and its preparation method and application | |
| KR101783549B1 (en) | Health supplement food containing dha for recovering fatigue, and method of manufacturing the same | |
| CN115336749A (en) | Flaxseed composition rich in omega-3 polyunsaturated fatty acids and preparation method thereof | |
| CN103301306A (en) | Korla bergamot pear lozenge for relieving cough and asthma | |
| CN103695157A (en) | Health-care sesame oil having efficacies on replenishing blood and lubricating intestines | |
| CN107114547A (en) | Pressed candy | |
| CN103719863B (en) | Preparation method of red ginseng chewable tablets | |
| CN102783611A (en) | Manufacture process of polished round-grained rice containing rich gypenoside | |
| CN106262980A (en) | A kind of yellow olive breaking method | |
| KR101875896B1 (en) | Health supplement food comprising horse bone and coral, and manufacturing method for the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |
|
| RJ01 | Rejection of invention patent application after publication |